Email this article Do statins increase the risk of tendon rupture? A qualitative systematic review
Abstract
Materials and methods: A search was conducted of studies on the statin-related risk of tendon disorders, published in English until August 2022. It included randomized control trials, experimental studies on human tendon samples and animal tendons, cohort studies, case series, and case reports. The data was then extracted and qualitatively reviewed. The results were tabulated and structured into increased risk, reduced risk, and no effect of statin in tendon disorders.
Results: Out of 48 studies, 17 articles indicated an increased risk of tendon disorders, 6 articles found no correlation between statin use and tendinopathy, 7 articles reported decreased risk, and further 6 articles merely mentioned a tendon disorder and statin use without drawing conclusions. The remaining 12 articles were case reports with bilateral quadriceps tendon rupture as the most mentioned tendon disorder.
Conclusions: Overall, statins did not seem to increase the risk of tendon disorders in a clinical setting. However, in experimental studies, statins were shown to increase the risk. It is presumed that this is due to prescribing statins in hyperlipidemia, which is a risk factor itself for tendon disorders. Controversially, statins exhibit a tendon healing property in in vitro conducted studies. Further studies are needed to explore the effects of statins on tendons.
Keywords
Full Text:
PDFReferences
Stancu C, Sima A. Statins: mechanism of action and effects. J Cell Mol Med 2001;5(4):378-87.
US Preventive Services Task Force, Mangione CM, Barry MJ, Nicholson WK, Cabana M, Chelmow D, et al. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force Recommendation statement. JAMA 2022;328(8):746-53.
Libby P, Aikawa M. Mechanisms of plaque stabilization with statins. Am J Cardiol 2003;91(4A):4B-8B.
Takata K, Imaizumi S, Zhang B, Miura S, Saku K. Stabilization of high-risk plaques. Cardiovasc Diagn Ther 2016;6(4):304-21.
Endo A. A historical perspective on the discovery of statins. Proc Jpn Acad Ser B Phys Biol Sci 2010;86(5):484-93.
Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Statins: pros and cons. Med Clin (Barc) 2018;150(10):398-402.
Ramkumar S, Raghunath A, Raghunath S. Statin therapy: review of safety and potential side effects. Acta Cardiol Sin 2016;32(6):631-9.
Bełtowski J, Wójcicka G, Jamroz-Wiśniewska A. Adverse effects of statins – mechanisms and consequences. Curr Drug Saf 2009;4(3):209-28.
Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs 2008;8(6):373-418.
Zhou Q, Liao JK. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr Pharm Des 2009;15(5):467-78.
Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343(6257):425-30.
Van Aelst L, D’Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev 1997;11(18):2295-322.
Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89-118.
Hall A. Rho GTPases and the actin cytoskeleton. Science 1998;279(5350):509-14.
Björklund MA, Vaahtomeri K, Peltonen K, Viollet B, Mäkelä TP, Band AM, et al. Non-CDK-bound p27 (p27(NCDK)) is a marker for cell stress and is regulated through the Akt/PKB and AMPK-kinase pathways. Exp Cell Res 2010;316(5):762-74.
Dehnavi S, Kiani A, Sadeghi M, Biregani AF, Banach M, Atkin SL, et al. Targeting AMPK by statins: a potential therapeutic approach. Drugs 2021;81(8):923-33.
O’Neill LAJ, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013;493(7432):346-55.
Sharma P, Maffulli N. Tendon injury and tendinopathy: healing and repair. J Bone Joint Surg Am 2005;87(1):187-202.
Dyment NA, Galloway JL. Regenerative biology of tendon: mechanisms for renewal and repair. Curr Mol Biol Rep 2015;1(3):124-31.
Kannus P, Paavola M, Józsa L. Aging and degeneration of tendons. In: Maffulli N, Renström P, Leadbetter WB, editors. Tendon injuries: Basic science and clinical medicine. London: Springer; 2005. p. 25-31.
Vailas AC, Tipton CM, Laughlin HL, Tcheng TK, Matthes RD. Physical activity and hypophysectomy on the aerobic capacity of ligaments and tendons. J Appl Phys-iol Respir Environ Exerc Physiol 1978;44(4):542-6.
Williams JG. Achilles tendon lesions in sport. Sports Med 1986;3(2):114-35.
Carr AJ, Norris SH. The blood supply of the calcaneal tendon. J Bone Joint Surg Br 1989;71(1):100-1.
Naito M, Ogata K. The blood supply of the tendon with a paratenon. An experimental study using hydrogen washout technique. Hand 1983;15(1):9-14.
Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6(10):772-83.
Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through inter-leukin-10 expression in human macrophages. Circulation 2004;109(17):2046-9.
Wu H, Ballantyne CM. metabolic inflammation and insulin resistance in obesity. Circ Res 2020;126(11):1549-64.
Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009;15(8):914-20.
Wang Q, Wu H. T cells in adipose tissue: critical players in immunometabolism. Front Immunol 2018;9:2509.
Lui PPY, Yung PSH. Inflammatory mechanisms linking obesity and tendinopathy. J Orthop Translat 2021;31:80-90.
Yang Y, Lu H, Qu J. Tendon pathology in hypercholesterolaemia patients: Epidemiology, pathogenesis and management. J Orthop Translat 2018;16:14-22.
Eliasson P, Dietrich-Zagonel F, Lundin AC, Aspenberg P, Wolk A, Michaëlsson K. Statin treatment increases the clinical risk of tendinopathy through matrix metalloproteinase release – a cohort study design combined with an experimental study. Sci Rep 2019;9(1):17958. doi: 10.1038/s41598-019-53238-7.
Kirchgesner T, Larbi A, Omoumi P, Malghem J, Zamali N, Manelfe J, et al. Drug-induced tendinopathy: from physiology to clinical applications. Joint Bone Spine 2014;81(6):485-92.
Kuzma-Kuzniarska M, Cornell HR, Moneke MC, Carr AJ, Hulley PA. Lovastatin-mediated changes in human tendon cells. J Cell Physiol 2015;230(10):2543-51.
Govindu R, Ammar H, George V. Bilateral quadriceps tendon rupture. J Clin Rheumatol 2019;25(5):e63-6.
Gowdar SD, Thompson PD. Multiple tendon ruptures associated with statin therapy. J Clin Lipidol 2020;14(2):189-91.
Patel M, Carayannopoulos NL. Simultaneous bilateral quadriceps tendon rupture with remote, short-term, low-dose statin use. Curr Orthop Pract 2017;28(1):112-5.
Cano Cevallos EJ, Shaikh DH, Gonzalez J, Sanchez W, Patel M. Tendon rupture associated with concomitant simvastatin and gemfibrozil use: Biological and pharmacokinetic implications. Clin Case Rep 2019;7(10):1919-22.
Celik EC, Ozbaydar M, Ofluoglu D, Demircay E. Simultaneous and spontaneous bilateral quadriceps tendons rupture. Am J Phys Med Rehabil 2012;91(7):631-4.
Carmont MR, Highland AM, Blundell CM, Davies MB. Simultaneous bilateral Achilles tendon ruptures associated with statin medication despite regular rock climbing exercise. Phys Ther Sport 2009;10(4):150-2.
Pullatt RC, Gadarla MR, Karas RH, Alsheikh-Ali AA, Thompson PD. Tendon rupture associated with simvastatin/ezetimibe therapy. Am J Cardiol 2007;100(1):152-3.
Kearns MC, Singh VK. Bilateral patellar tendon rupture associated with statin use. J Surg Case Rep 2016;2016(5):rjw072.
Nesselroade RD, Nickels LC. Ultrasound diagnosis of bilateral quadriceps tendon rupture after statin use. West J Emerg Med 2010;11(4):306-9.
Chazerain P, Hayem G, Hamza S, Best C, Ziza JM. Four cases of tendinopathy in patients on statin therapy. Joint Bone Spine 2001;68(5):430-3.
Moniri NH, Momary KM, McMahon T, Nayee E. Statin-associated achilles tendon rupture and reproducible bilateral tendinopathy on repeated exposure. Mayo Clin Proc 2018;93(10):1531-2.
Rubin G, Haddad E, Ben-Haim T, Elmalach I, Rozen N. Bilateral, simultaneous rupture of the quadriceps tendon associated with simvastatin. Isr Med Assoc J 2011;13(3):185-6.
Chang CK, Chien WC, Hsu WF, Chiao HY, Chung CH, Tzeng YS, et al. Positive association between fluoroquinolone exposure and tendon disorders: a nationwide population-based cohort study in Taiwan. Front Pharmacol 2022;13:814333.
Wang Y, Jones G, Hill C, Wluka AE, Forbes AB, Tonkin A, et al. Effect of atorvastatin on knee cartilage volume in patients with symptomatic knee osteoarthritis: results from a randomized placebo-controlled trial. Arthritis Rheumatol 2021;73(11):2035-43.
Cong XX, Rao XS, Lin JX, Liu XC, Zhang GA, Gao XK, et al. Activation of AKT-mTOR signaling directs tenogenesis of mesenchymal stem cells. Stem Cells 2018;36(4):527-39.
Kaleağasıoğlu F, Olcay E, Olgaç V. Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin. Knee Surg Sports Traumatol Arthrosc 2017;25(6):1884-91.
Eliasson P, Svensson RB, Giannopoulos A, Eismark C, Kjær M, Schjerling P, et al. Simvastatin and atorvastatin reduce the mechanical properties of tendon constructs in vitro and introduce catabolic changes in the gene expression pattern. PLoS One 2017;12(3):e0172797.
Oliveira LP, Vieira CP, Marques PP, Pimentel ER. Do different tendons exhibit the same response following chronic exposure to statins? Can J Physiol Pharmacol 2017;95(4):333-9.
Tsai WC, Yu TY, Lin LP, Cheng ML, Chen CL, Pang JHS. Prevention of simvastatin-induced inhibition of tendon cell proliferation and cell cycle progression by geranylgeranyl pyrophosphate. Toxicol Sci 2016;149(2):326-34.
de Oliveira LP, Vieira CP, Da Ré Guerra F, de Almeida M dos S, Pimentel ER. Statins induce biochemical changes in the Achilles tendon after chronic treatment. Toxicology 2013;311(3):162-8.
Hoffman KB, Kraus C, Dimbil M, Golomb BA. A survey of the FDA’s AERS database regarding muscle and tendon adverse events linked to the statin drug class. PLoS One 2012;7(8):e42866.
Savvidou C, Moreno R. Spontaneous distal biceps tendon ruptures: are they related to statin administration? Hand Surg 2012;17(2):167-71.
Marie I, Delafenêtre H, Massy N, Thuillez C, Noblet C. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature. Arthritis Rheum 2008;59(3):367-72.
Ekhart C, de Jong L, Gross-Martirosyan L, van Hunsel F. Muscle rupture associated with statin use. Br J Clin Pharmacol 2016;82(2):473-7.
de Oliveira LP, Vieira CP, Guerra FD, Almeida MS, Pimentel ER. Structural and biomechanical changes in the Achilles tendon after chronic treatment with statins. Food Chem Toxicol 2015;77:50-7.
Beri A, Dwamena FC, Dwamena BA. Association between statin therapy and tendon rupture: a case-control study. J Cardiovasc Pharmacol 2009;53(5):401-4.
Rafi JA, Arabyat R, Chen C, Raisch DW. Hmg-Coa reductase inhibitors (statins) associated tendon rupture: an analysis of reports from the food and drug administration’s adverse reporting system. Value Health 2016;19(3):A39. doi: 10.1016/j.jval.2016.03.066.
Morales DR, Slattery J, Pacurariu A, Pinheiro L, McGettigan P, Kurz X. Relative and absolute risk of tendon rupture with fluoroquinolone and concomitant fluoroquinolone/corticosteroid therapy: population-based nested case-control study. Clin Drug Investig 2019;39(2):205-13.
de Sá A, Hart DA, Khan K, Scott A. Achilles tendon structure is negatively correlated with body mass index, but not influenced by statin use: A cross-sectional study using ultrasound tissue characterization. PLoS One 2018;13(6):e0199645.
Choi DS, Shetye SS, Tucker JJ, Huegel J, Soslowsky LJ. Simvastatin does not adversely affect Achilles tendon properties in a diet induced hypercholesterolemia rat model. Muscles Ligaments Tendons J 2018;8(2):199-205.
Bakker EA, Timmers S, Hopman MTE, Thompson PD, Verbeek ALM, Eijsvogels TMH. Association between statin use and prevalence of exercise-related injuries: a cross-sectional survey of amateur runners in the Netherlands. Sports Med 2017;47(9):1885-92.
Spoendlin J, Layton JB, Mundkur M, Meier C, Jick SS, Meier CR. The risk of Achilles or biceps tendon rupture in new statin users: a propensity score-matched sequential cohort study. Drug Saf 2016;39(12):1229-37.
Contractor T, Beri A, Gardiner JC, Tang X, Dwamena FC. Is statin use associated with tendon rupture? A population-based retrospective cohort analysis. Am J Ther 2015;22(5):377-81.
Weng CJ, Liao CT, Hsu MY, Chang FP, Liu SJ. Simvastatin-loaded nanofibrous membrane efficiency on the repair of Achilles tendons. Int J Nanomedicine 2022;17:1171-84.
Amit P, Kuiper JH, James S, Snow M. Does statin-treated hyperlipidemia affect rotator cuff healing or muscle fatty infiltration after rotator cuff repair? J Shoulder Elbow Surg 2021;30(11):2465-74.
Coombes BK, Tucker K, Hug F, Scott A, Geytenbeek M, Cox ER, et al. Relationships between cardiovascular disease risk factors and Achilles tendon structural and mechanical properties in people with Type 2 Diabetes. Muscle Ligaments Tendons J 2019;9(3):395-404.
Jeong C, Kim SE, Shim KS, Kim HJ, Song MH, Park K, et al. Exploring the in vivo anti-inflammatory actions of simvastatin-loaded porous microspheres on inflamed tenocytes in a collagenase-induced animal model of Achilles tendinitis. Int J Mol Sci 2018;19(3):820.
Dolkart O, Liron T, Chechik O, Somjen D, Brosh T, Maman E, et al. Statins enhance rotator cuff healing by stimulating the COX2/PGE2/EP4 pathway: an in vivo and in vitro study. Am J Sports Med 2014;42(12):2869-76.
Oka S, Matsumoto T, Kubo S, Matsushita T, Sasaki H, Nishizawa Y, et al. Local administration of low-dose simvastatin-conjugated gelatin hydrogel for tendon-bone healing in anterior cruciate ligament reconstruction. Tissue Eng Part A 2013;19(9-10):1233-43.
Lin TTL, Lin CH, Chang CL, Chi CH, Chang ST, Sheu WHH. The effect of diabetes, hyperlipidemia, and statins on the development of rotator cuff disease: a nationwide, 11-year, longitudinal, population-based follow-up study. Am J Sports Med 2015;43(9):2126-32.
Lee HY, Han KH, Chung WB, Her SH, Park TH, Rha SW, et al. Safety and efficacy of pitavastatin in patients with impaired fasting glucose and hyperlipidemia: a randomized, open-labeled, multicentered, phase IV study. Clin Ther 2020;42(10):2036-48.
Kheloufi F, Default A, Blin O, Micallef J. Investigating patient narratives posted on Internet and their informativeness level for pharmacovigilance purpose: the example of comments about statins. Therapie 2017;72(4):483-90.
Carnovale C, Gentili M, Fortino I, Merlino L, Clementi E, Radice S, et al. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme. Expert Opin Drug Saf 2016;15(2):131-9.
Choi NK, Chang Y, Choi YK, Hahn S, Park BJ. Signal detection of rosuvastatin compared to other statins: data-mining study using national health insurance claims database. Pharmacoepidemiol Drug Saf 2010;19(3):238-46.
Mignini F, Tomassoni D, Streccioni V, Traini E, Amenta F. Pharmacokinetics and bioequivalence study of two tablet formulations of lovastatin in healthy volunteers. Clin Exp Hypertens 2008;30(2):95-108.
Ballantyne CM, Miller E, Chitra R. Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trial. Clin Ther 2004;26(11):1855-64.
Weis M, Heeschen C, Glassford AJ, Cooke JP. Statins have biphasic effects on angiogenesis. Circulation 2002;105(6):739-45.
Urbich C, Dernbach E, Zeiher AM, Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res 2002;90(6):737-44.
Skaletz-Rorowski A, Walsh K. Statin therapy and angiogenesis. Curr Opin Lipidol 2003;14(6):599-603.
DOI: https://doi.org/10.21164/pomjlifesci.923
Copyright (c) 2023 Markus Jaschke
License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/